================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 15, 2005
------------------------
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-32431 90-0199783
-------- --------- ----------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
100 Potrero Avenue
San Francisco, CA 94103-4813
(Address of principal executive offices, including zip code)
(415) 558-0200
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 7.01. Regulation FD Disclosure.
On August 15, 2005, Dolby Laboratories, Inc. (the "Company") issued a press
release announcing an update to its guidance for its fiscal year ending
September 30, 2005. A copy of the press release issued by the Company concerning
the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated
herein by reference.
This information shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
ITEM 9.01. Financial Statements and Exhibits.
(c) Exhibits
The following exhibits are filed herewith:
Exhibit No. Description
----------- -----------
99.1 Press release, dated August 15, 2005, entitled "Dolby
Laboratories Updates Fiscal 2005 Financial Guidance"
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC.
By:/s/ Martin Jaffe
----------------------------------------------
Martin Jaffe
Executive Vice President, Business and Finance
Date: August 15, 2005
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press release, dated August 15, 2005, entitled "Dolby
Laboratories Updates Fiscal 2005 Financial Guidance"